Follow
Lidia Ruiz Llorente
Lidia Ruiz Llorente
Profesor, UAH
No verified email
Title
Cited by
Cited by
Year
Activation of phosphoinositide 3-kinase/PKB pathway by CB1 and CB2 cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction
MG Sánchez, L Ruiz-Llorente, AM Sánchez, I Dı́az-Laviada
Cellular signalling 15 (9), 851-859, 2003
2222003
Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer
O Martínez-Iglesias, L Ruiz-Llorente, R Sánchez-Martínez, L García, ...
Clinical and Translational Oncology 10 (7), 395-398, 2008
1342008
Thyroid receptor: roles in cancer
A Aranda, O Martínez-Iglesias, L Ruiz-Llorente, V García-Carpizo, ...
Trends in Endocrinology & Metabolism 20 (7), 318-324, 2009
1132009
Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia
L Ruiz-Llorente, E Gallardo-Vara, E Rossi, DM Smadja, LM Botella, ...
Expert opinion on therapeutic targets 21 (10), 933-947, 2017
992017
Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses
E Alonso-Merino, R Martin Orozco, L Ruíz-Llorente, OA Martínez-Iglesias, ...
Proceedings of the National Academy of Sciences 113 (24), E3451-E3460, 2016
882016
Signal transduction activated by cannabinoid receptors
I Díaz-Laviada, L Ruiz-Llorente
Mini reviews in medicinal chemistry 5 (7), 619-630, 2005
762005
Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells
MG Sánchez, AM Sánchez, L Ruiz-Llorente, I Dı́az-Laviada
FEBS letters 555 (3), 561-566, 2003
612003
The growing role of gene methylation on endocrine function
V Garcia-Carpizo, L Ruiz Llorente, M Fernández Fraga, A Aranda
Journal of Molecular Endocrinology, 2011
512011
microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta
L Ruiz-Llorente, S Ardila-González, LF Fanjul, O Martínez-Iglesias, ...
Oncotarget 5 (10), 2918, 2014
472014
Characterization of an anandamide degradation system in prostate epithelial PC‐3 cells: synthesis of new transporter inhibitors as tools for this study
L Ruiz‐Llorente, S Ortega‐Gutiérrez, A Viso, MG Sánchez, AM Sánchez, ...
British journal of pharmacology 141 (3), 457-467, 2004
392004
Thyroid hormone receptor β1 domains responsible for the antagonism with the ras oncogene: role of corepressors
S García-Silva, O Martínez-Iglesias, L Ruiz-Llorente, A Aranda
Oncogene 30 (7), 854-864, 2011
382011
Expression of functionally active cannabinoid receptor CB1 in the human prostate gland
L Ruiz‐Llorente, MG Sánchez, MJ Carmena, JC Prieto, ...
The Prostate 54 (2), 95-102, 2003
352003
Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an “HHT‐like” syndrome in children
J Hodgson, L Ruiz‐Llorente, J McDonald, O Quarrell, K Ugonna, ...
Molecular Genetics & Genomic Medicine 9 (12), e1685, 2021
342021
Endoglin protein interactome profiling identifies TRIM21 and Galectin-3 as new binding partners
E Gallardo-Vara, L Ruiz-Llorente, J Casado-Vela, MJ Ruiz-Rodríguez, ...
Cells 8 (9), 1082, 2019
302019
Impaired hair growth and wound healing in mice lacking thyroid hormone receptors
C Contreras-Jurado, L García-Serrano, M Martínez-Fernández, ...
PloS one 9 (9), e108137, 2014
292014
Cellular endocrinology in health and disease
A Ulloa-Aguirre, YX Tao
Academic Press, 2021
272021
The thyroid hormone receptors as tumor suppressors
L Ruiz-Llorente, O Martínez-Iglesias, S García-Silva, S Tenbaum, ...
Hormone Molecular Biology and Clinical Investigation 5 (2), 79-89, 2011
132011
Thyroid hormone receptors regulate the expression of microRNAs with key roles in skin homeostasis
L Ruiz-Llorente, C Contreras-Jurado, M Martínez-Fernández, JM Paramio, ...
Thyroid 28 (7), 921-932, 2018
122018
Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved
LG Guijarro, D Cano-Martínez, MV Toledo-Lobo, PS Salinas, M Chaparro, ...
Biomedicine & Pharmacotherapy 144, 112239, 2021
112021
Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives
L Pekarek, O Fraile‑Μartinez, C Garcia‑Montero, MA Alvarez‑Mon, ...
Oncology Letters 22 (5), 1-11, 2021
102021
The system can't perform the operation now. Try again later.
Articles 1–20